NeuBase Therapeutics Inc.(NBSE)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

NBSE NeuBase Therapeutics Inc.

交易中 12-19 14:09:35 EST

0.3780

+0.0000

0.00%

最高0.3780	最低0.3780	成交量0.00
今开0.3780	昨收0.3780	日振幅0.00%
总市值141.81万	流通市值125.53万	总股本375.16万
成交额0.00	换手率0.00%	流通股本332.09万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"NBSE","market":"US","secType":"STK","nameCN":"NeuBase Therapeutics Inc.","latestPrice":0.378,"timestamp":1734635375063,"preClose":0.378,"halted":0,"volume":0,"delay":0,"floatShares":3320901,"shares":3751590,"eps":-15.008684,"marketStatus":"交易中","marketStatusCode":2,"change":0,"latestTime":"12-19 14:09:35 EST","open":0.378,"high":0.378,"low":0.378,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-15.008684,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1734642000000},"adr":0,"listingDate":1371096000000,"adjPreClose":0.378,"volumeRatio":0,"impliedVol":1.5798,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/NBSE","defaultTab":"news","newsList":[{"id":"2428665042","title":"Neubase Therapeutics, Inc.盘中异动 大幅下跌5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2428665042","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2428665042?lang=zh_cn&edition=full","pubTime":"2024-04-19 23:31","pubTimestamp":1713540661,"startTime":"0","endTime":"0","summary":"北京时间2024年04月19日23时31分，Neubase Therapeutics, Inc.股票出现波动，股价大幅下挫5.21%。Neubase Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.11%。其相关个股中，Lexaria Bioscience Corp C/Wts 14/01/2026 、Chromocell Therapeutics Corporation、Portage Biotech Inc.涨幅较大，Bio-Path Holdings, Inc.、Kintara Therapeutics, Inc.、Gri Bio, Inc.较为活跃，换手率分别为211.70%、11.36%、9.44%，振幅较大的相关个股有Chromocell Therapeutics Corporation、Portage Biotech Inc.、Brainstorm Cell Therapeutics Inc.，振幅分别为34.28%、27.12%、24.64%。Neubase Therapeutics, Inc.公司简介：NeuBase Therapeutics Inc 是一家处于临床前阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041923310187964bae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041923310187964bae&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NBSE","BK4139","LENZ"],"gpt_icon":0},{"id":"2428345419","title":"Neubase Therapeutics, Inc.盘中异动 股价大涨6.97%报0.430美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2428345419","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2428345419?lang=zh_cn&edition=full","pubTime":"2024-04-17 21:30","pubTimestamp":1713360623,"startTime":"0","endTime":"0","summary":"北京时间2024年04月17日21时30分，Neubase Therapeutics, Inc.股票出现波动，股价急速上涨6.97%。截至发稿，该股报0.430美元/股，成交量2621股，换手率0.07%，振幅0.00%。Neubase Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Vanda Pharmaceuticals Inc.、Clene Inc.、Purple Biotech Ltd涨幅较大，Clearmind Medicine Inc.、Novabay Pharmaceuticals, Inc.、Longeveron Inc.较为活跃，换手率分别为24.04%、21.24%、14.99%，振幅较大的相关个股有Coya Therapeutics, Inc.、180 Life Sciences Corp.、Vanda Pharmaceuticals Inc.，振幅分别为5.51%、4.73%、4.44%。Neubase Therapeutics, Inc.公司简介：NeuBase Therapeutics Inc 是一家处于临床前阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404172130237a537b30&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404172130237a537b30&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NBSE","LENZ"],"gpt_icon":0},{"id":"2422561587","title":"Neubase Therapeutics, Inc.盘中异动 早盘股价大跌52.64%报0.474美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2422561587","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2422561587?lang=zh_cn&edition=full","pubTime":"2024-03-26 21:31","pubTimestamp":1711459893,"startTime":"0","endTime":"0","summary":"北京时间2024年03月26日21时31分，Neubase Therapeutics, Inc.股票出现异动，股价急速下跌52.64%。Neubase Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.41%。其相关个股中，Stoke Therapeutics, Inc.、180 Life Sciences Corp C/Wts 07/11/2025、Abvc Biopharma, Inc.涨幅较大，Abvc Biopharma, Inc.、Xtl生物制药、Stoke Therapeutics, Inc.较为活跃，换手率分别为98.13%、10.77%、9.11%，振幅较大的相关个股有Stoke Therapeutics, Inc.、Molecular Templates, Inc.、安皮奥制药，振幅分别为24.77%、14.64%、9.54%。Neubase Therapeutics, Inc.公司简介：NeuBase Therapeutics Inc 是一家处于临床前阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032621313387b7c854&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032621313387b7c854&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NBSE","LENZ"],"gpt_icon":0},{"id":"2420672146","title":"Neubase Therapeutics, Inc.盘中异动 大幅上涨7.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2420672146","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2420672146?lang=zh_cn&edition=full","pubTime":"2024-03-20 23:02","pubTimestamp":1710946975,"startTime":"0","endTime":"0","summary":"北京时间2024年03月20日23时02分，Neubase Therapeutics, Inc.股票出现异动，股价快速拉升7.77%。Neubase Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.98%。其相关个股中，Xtl生物制药、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Moolec Science Sa C/Wts 涨幅较大，Jaguar Health, Inc.、Tc Biopharm  Plc、Xtl生物制药较为活跃，换手率分别为72.60%、39.97%、34.79%，振幅较大的相关个股有Xtl生物制药、Jaguar Health, Inc.、Nls Pharmaceutics Ltd.，振幅分别为100.96%、38.90%、33.85%。Neubase Therapeutics, Inc.公司简介：NeuBase Therapeutics Inc 是一家处于临床前阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240320230255861dfca1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240320230255861dfca1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NBSE"],"gpt_icon":0},{"id":"2415378354","title":"Neubase Therapeutics Inc盘中异动 早盘股价大跌5.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2415378354","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2415378354?lang=zh_cn&edition=full","pubTime":"2024-02-28 22:51","pubTimestamp":1709131863,"startTime":"0","endTime":"0","summary":"北京时间2024年02月28日22时51分，Neubase Therapeutics Inc股票出现异动，股价急速下挫5.82%。Neubase Therapeutics Inc股票所在的生物技术行业中，整体跌幅为0.21%。其相关个股中，Vivani Medical Inc、Adial Pharmaceuticals Inc、Dermata Therapeutics Inc C/Wts 13/08/2026 涨幅较大，Adial Pharmaceuticals Inc、Vivani Medical Inc、Zyversa Therapeutics Inc较为活跃，换手率分别为367.58%、121.42%、60.31%，振幅较大的相关个股有Vivani Medical Inc、Psyence Biomedical Ltd C/Wts 25/01/2029、Adial Pharmaceuticals Inc，振幅分别为323.76%、86.89%、80.14%。Neubase Therapeutics Inc公司简介：NeuBase Therapeutics Inc 是一家处于临床前阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022822510479158d2f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022822510479158d2f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NBSE","BK4139"],"gpt_icon":0},{"id":"2414009562","title":"BUZZ-NeuBase 因计划清算和分配资产而上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2414009562","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2414009562?lang=zh_cn&edition=full","pubTime":"2024-02-26 18:02","pubTimestamp":1708941730,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    2月26日 - ** NeuBase Therapeutics    股价盘前上涨约 22.2% 至 87 美分** 该公司周五晚些时候在 (link) 上表示，已决定解散、清算并向股东分配其可用资产。** 董事会预计将在不久的将来批准正式的解散计划 - NBSE** 该公司表示，它一直在评估各种战略选择，包括收购、合并、业务组合、解散或其他交易。** 截至上次收盘，股价在过去 12 个月中下跌了 85.5","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NBSE","BK4139","BUZZ"],"gpt_icon":0},{"id":"2413421408","title":"Neubase Therapeutics Inc盘中异动 大幅上涨7.05%报0.790美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2413421408","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2413421408?lang=zh_cn&edition=full","pubTime":"2024-02-21 22:30","pubTimestamp":1708525858,"startTime":"0","endTime":"0","summary":"北京时间2024年02月21日22时30分，Neubase Therapeutics Inc股票出现波动，股价大幅上涨7.05%。截至发稿，该股报0.790美元/股，成交量301股，换手率0.01%，振幅0.00%。Neubase Therapeutics Inc股票所在的生物技术行业中，整体涨幅为0.00%。Neubase Therapeutics Inc公司简介：NeuBase Therapeutics Inc 是一家处于临床前阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240221223058861d714c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240221223058861d714c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NBSE"],"gpt_icon":0},{"id":"2406324635","title":"Neubase Therapeutics Inc盘中异动 急速上涨5.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2406324635","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2406324635?lang=zh_cn&edition=full","pubTime":"2024-01-25 23:53","pubTimestamp":1706197993,"startTime":"0","endTime":"0","summary":"北京时间2024年01月25日23时53分，Neubase Therapeutics Inc股票出现异动，股价快速上涨5.45%。截至发稿，该股报0.635美元/股，成交量4070股，换手率0.11%，振幅0.40%。Neubase Therapeutics Inc股票所在的生物技术行业中，整体涨幅为0.13%。其相关个股中，Onconetix Inc、Processa Pharmaceuticals Inc、Apollomics Inc C/Wts 01/04/2028 涨幅较大，Processa Pharmaceuticals Inc、Onconetix Inc、Lava Therapeutics Nv较为活跃，换手率分别为3698.23%、447.86%、126.12%，振幅较大的相关个股有Processa Pharmaceuticals Inc、Onconetix Inc、Clearmind Medicine Inc，振幅分别为111.70%、83.38%、46.98%。Neubase Therapeutics Inc公司简介：NeuBase Therapeutics Inc 是一家处于临床前阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024012523531387e68b0e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024012523531387e68b0e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NBSE"],"gpt_icon":0},{"id":"2404367684","title":"BUZZ-NeuBase 更换首席执行官后业绩攀升","url":"https://stock-news.laohu8.com/highlight/detail?id=2404367684","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2404367684?lang=zh_cn&edition=full","pubTime":"2024-01-18 02:36","pubTimestamp":1705516570,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    1月17日 - ** 生物技术公司NeuBase Therapeutics   股价上涨4%至62美分，将结束6天连跌。** 公司称无故终止首席执行官迪特里希-斯蒂芬的职务，并任命首席财务官托德-布兰宁（Todd Branning）担任该职务** Branning 自 2022 年 1 月起一直担任公司财务总监，在担任临时首席执行官期间将继续担任这一职务** 自斯蒂芬于 2019 年接任首席执行官以来，该公司的股票几乎贬值殆尽；在过去的 12 个月里，股票下跌了 89.3%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BUZZ","BK4139","NBSE"],"gpt_icon":0},{"id":"2404351297","title":"Neubase Therapeutics Inc盘中异动 股价大涨8.14%报0.650美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2404351297","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2404351297?lang=zh_cn&edition=full","pubTime":"2024-01-17 22:38","pubTimestamp":1705502289,"startTime":"0","endTime":"0","summary":"北京时间2024年01月17日22时38分，Neubase Therapeutics Inc股票出现异动，股价急速拉升8.14%。截至发稿，该股报0.650美元/股，成交量4008股，换手率0.11%，振幅0.10%。Neubase Therapeutics Inc股票所在的生物技术行业中，整体跌幅为0.36%。Neubase Therapeutics Inc公司简介：NeuBase Therapeutics Inc 是一家处于临床前阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202401172238107a3bf93a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202401172238107a3bf93a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NBSE"],"gpt_icon":0},{"id":"2402483654","title":"Neubase Therapeutics Inc盘中异动 早盘股价大跌6.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2402483654","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2402483654?lang=zh_cn&edition=full","pubTime":"2024-01-10 23:09","pubTimestamp":1704899389,"startTime":"0","endTime":"0","summary":"北京时间2024年01月10日23时09分，Neubase Therapeutics Inc股票出现异动，股价急速跳水6.39%。Neubase Therapeutics Inc股票所在的生物技术行业中，整体跌幅为0.04%。其相关个股中，Pasithea Therapeutics Corp C/Wts 12/08/2026 、Effector Therapeutics Inc C/Wts 31/12/2025 、Sana Biotechnology Inc涨幅较大，Clearmind Medicine Inc、Neximmune Inc、安皮奥制药较为活跃，换手率分别为2020.83%、206.83%、101.34%，振幅较大的相关个股有Sana Biotechnology Inc、Clearmind Medicine Inc、Clene Inc C/Wts 30/12/2025 ，振幅分别为68.09%、42.99%、37.90%。Neubase Therapeutics Inc公司简介：NeuBase Therapeutics Inc 是一家处于临床前阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202401102309497907c7a6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202401102309497907c7a6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NBSE","BK4139"],"gpt_icon":0},{"id":"2392818660","title":"Neubase Therapeutics Inc盘中异动 下午盘股价大跌5.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2392818660","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2392818660?lang=zh_cn&edition=full","pubTime":"2023-12-20 02:51","pubTimestamp":1703011866,"startTime":"0","endTime":"0","summary":"北京时间2023年12月20日02时51分，Neubase Therapeutics Inc股票出现波动，股价大幅跳水5.47%。Neubase Therapeutics Inc股票所在的生物技术行业中，整体跌幅为0.01%。其相关个股中，Compugen医疗、Panbela Therapeutics Inc、180 Life Sciences Corp C/Wts 07/11/2025涨幅较大，Panbela Therapeutics Inc、Compugen医疗、Zyversa Therapeutics Inc较为活跃，换手率分别为1550.49%、105.84%、64.32%，振幅较大的相关个股有Celularity Inc C/Wts 16/07/2026 、Compugen医疗、Panbela Therapeutics Inc，振幅分别为201.92%、116.44%、47.52%。Neubase Therapeutics Inc公司简介：NeuBase Therapeutics Inc 是一家处于临床前阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023122002510683a52196&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023122002510683a52196&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NBSE","BK4139"],"gpt_icon":0},{"id":"2390037874","title":"Neubase Therapeutics Inc盘中异动 大幅下跌5.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2390037874","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2390037874?lang=zh_cn&edition=full","pubTime":"2023-12-12 22:36","pubTimestamp":1702391803,"startTime":"0","endTime":"0","summary":"北京时间2023年12月12日22时36分，Neubase Therapeutics Inc股票出现异动，股价急速下跌5.37%。截至发稿，该股报0.767美元/股，成交量1900股，换手率0.05%，振幅5.37%。Neubase Therapeutics Inc股票所在的生物技术行业中，整体跌幅为0.16%。其相关个股中，C4 Therapeutics Inc、Candel Therapeutics Inc、Icosavax Inc涨幅较大，C4 Therapeutics Inc、Candel Therapeutics Inc、Altamira Therapeutics Ltd较为活跃，换手率分别为63.51%、40.31%、23.78%，振幅较大的相关个股有Candel Therapeutics Inc、Elevai Labs Inc、C4 Therapeutics Inc，振幅分别为20.73%、16.22%、14.41%。Neubase Therapeutics Inc公司简介：NeuBase Therapeutics Inc 是一家处于临床前阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023121222364384766fcd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023121222364384766fcd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NBSE"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.neubasetherapeutics.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":-0.4598},{"period":"ytd","weight":-0.4893}],"compareEarnings":[{"period":"1week","weight":-0.0349},{"period":"1month","weight":-0.0032},{"period":"3month","weight":0.0268},{"period":"6month","weight":0.0767},{"period":"1year","weight":0.2347},{"period":"ytd","weight":0.2335}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"NeuBase Therapeutics, Inc.2009年8月4日在特拉华州注册。该是一家生物技术公司，使用一种新的合成药物加速基因革命。他们的模块化肽核酸反义寡核苷酸输出“反基因”候选疗法的平台旨在将基于基因序列的靶点识别的特异性与模块化相结合，该模块化允许使用各种体内递送技术来实现广泛且选择性的组织分布能力。考虑到每一种人类疾病都可能有遗传成分，他们的差异化平台技术具有广泛影响的潜力，通过增加、减少或改变DNA或RNA水平上的基因功能来解决特定适应症的疾病进展。","yearOnYearQuotes":[{"month":1,"riseRate":0.363636,"avgChangeRate":-0.051606},{"month":2,"riseRate":0.545455,"avgChangeRate":-0.020666},{"month":3,"riseRate":0.272727,"avgChangeRate":-0.134531},{"month":4,"riseRate":0.363636,"avgChangeRate":-0.107823},{"month":5,"riseRate":0.272727,"avgChangeRate":-0.005084},{"month":6,"riseRate":0.545455,"avgChangeRate":-0.028902},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.021459},{"month":8,"riseRate":0.416667,"avgChangeRate":-0.039189},{"month":9,"riseRate":0.166667,"avgChangeRate":-0.043762},{"month":10,"riseRate":0.5,"avgChangeRate":-0.040989},{"month":11,"riseRate":0.5,"avgChangeRate":0.102936},{"month":12,"riseRate":0.333333,"avgChangeRate":0.018823}],"exchange":"NASDAQ","name":"NeuBase Therapeutics Inc.","nameEN":"NeuBase Therapeutics Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"NeuBase Therapeutics Inc.(NBSE)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供NeuBase Therapeutics Inc.(NBSE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"NeuBase Therapeutics Inc.,NBSE,NeuBase Therapeutics Inc.股票,NeuBase Therapeutics Inc.股票老虎,NeuBase Therapeutics Inc.股票老虎国际,NeuBase Therapeutics Inc.行情,NeuBase Therapeutics Inc.股票行情,NeuBase Therapeutics Inc.股价,NeuBase Therapeutics Inc.股市,NeuBase Therapeutics Inc.股票价格,NeuBase Therapeutics Inc.股票交易,NeuBase Therapeutics Inc.股票购买,NeuBase Therapeutics Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"NeuBase Therapeutics Inc.(NBSE)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供NeuBase Therapeutics Inc.(NBSE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}